ADMA Biologics, Inc.
ADMA
$16.57
-$0.01-0.06%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -15.04% | -29.20% | 2.31% | 58.03% | 100.86% |
| Total Receivables | 216.86% | 174.58% | 264.38% | 100.34% | 82.34% |
| Inventory | 21.28% | 14.47% | 6.48% | -3.12% | -1.54% |
| Prepaid Expenses | -7.11% | -27.40% | 46.42% | 129.59% | 50.52% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 40.77% | 26.54% | 31.57% | 27.28% | 28.95% |
|
|
|||||
| Total Current Assets | 40.77% | 26.54% | 31.57% | 27.28% | 28.95% |
| Net Property, Plant & Equipment | 13.21% | 25.86% | 4.70% | 1.57% | -0.20% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | 37.39% | 1.24% | 10.02% | 40.81% | -7.82% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -8.98% | 1,330.33% | 1,591.21% | 1,411.51% | 1,825.85% |
| Total Assets | 27.74% | 45.59% | 48.35% | 45.51% | 48.45% |
|
|
|||||
| Total Accounts Payable | 11.38% | 49.94% | 109.95% | 19.91% | 29.11% |
| Total Accrued Expenses | -3.30% | -3.07% | 4.92% | -26.82% | -6.30% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 220.94% | 205.28% | -1.31% | 8.69% | 16.56% |
| Total Finance Division Other Current Liabilities | 181.74% | 54.71% | 225.03% | 151.21% | 115.04% |
| Total Other Current Liabilities | 181.74% | 54.71% | 225.03% | 151.21% | 115.04% |
| Total Current Liabilities | 25.20% | 25.84% | 69.64% | 0.77% | 11.52% |
|
|
|||||
| Total Current Liabilities | 25.20% | 25.84% | 69.64% | 0.77% | 11.52% |
| Long-Term Debt | -4.16% | -30.83% | -44.00% | -44.57% | -44.61% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -22.37% | 6.00% | 1.30% | -12.53% | -12.46% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -56.37% | -58.04% | -34.65% | -24.55% | -15.20% |
| Total Liabilities | 5.20% | -13.37% | -14.92% | -30.44% | -28.00% |
|
|
|||||
| Common Stock & APIC | 2.05% | 2.00% | 2.52% | 2.02% | 2.52% |
| Retained Earnings | 47.61% | 49.81% | 45.78% | 42.33% | 39.05% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 36.76% | 85.94% | 111.57% | 142.94% | 158.14% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 36.76% | 85.94% | 111.57% | 142.94% | 158.14% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 36.76% | 85.94% | 111.57% | 142.94% | 158.14% |
|
|
|||||